Suppr超能文献

马凡综合征心血管表现的外科治疗

[Surgical treatment of cardiovascular manifestations of Marfan syndrome].

作者信息

Fukada J, Morishita K, Kawaharada N, Yamada A, Baba T, Harada N, Abe T

机构信息

Department of Cardiovascular Surgery, Sapporo Medical University, Sapporo, Japan.

出版信息

Kyobu Geka. 2002 Jul;55(8 Suppl):658-62.

Abstract

The present study determines the effect of surgical treatment of cardiovascular manifestations of Marfan syndrome in 72 patients by 114 operations, during 34-year period. This therapy resulted in aortic root repair, aortic arch replacement, or both in 78, mitral valve repair in 9, descending thoracic aortic replacement in 14, thoracoabdominal aortic replacement in 10, and abdominal aortic replacement in 6, including total aortic replacement in 4 and nearly total aortic replacement in 4 patients. Fusiform aneurysms were present in the the ascending aorta in 37, the aortic arch in 2, the thoracoabdominal aorta in 2, and the abdominal aorta in 6 patients. Aortic dissection occurred in 40 (55.6%), including type A aortic dissection in 29 patients. Aortic root repair included separate valve-graft in 8, Bentall composite valve-graft in 25, composite valve-graft with button technique in 26, composite valve-graft with interposition graft technique in 10, and valve sparing procedure in 5 patients. The overall early (30-day) mortality was 7.9%. The early survival was 75% in separate valve-graft procedure and 99.2% in composite valve-graft procedure. Late coronary dehiscence did not occur in the patients with Bentall technique in which the reattachments of coronary ostia were performed in 2 layers, but occurred in 50% of patients with the coronary anastomoses in 1 layer. Aortic valve regurgitation relapsed in 2 of the 5 patients with valve sparing procedure. Event free rate for the patients with composite valve-graft using button technique was 81.1% at 10 years. There were 14 late deaths; dissection or rupture of the residual aorta, composite graft endocarditis and cardiac failure were the principle causes of late deaths. In conclusion, Marfan patients with cardiovascular diseases can undergo surgical treatment with a low operative risk and low morbidity. Although late endocarditis remains a serious problem, we believe that Marfan syndrome is a contraindication for valve sparing procedure. Because of the potential for late dissection or aneurysm in other areas of the aorta, patients with Marfan syndrome should have serial computed tomographic scans indefinitely.

摘要

本研究确定了在34年期间对72例马方综合征心血管表现患者进行114次手术的外科治疗效果。该治疗导致78例患者进行主动脉根部修复、主动脉弓置换或两者皆有,9例患者进行二尖瓣修复,14例患者进行胸降主动脉置换,10例患者进行胸腹主动脉置换,6例患者进行腹主动脉置换,其中4例患者进行全主动脉置换,4例患者进行近乎全主动脉置换。37例患者升主动脉存在梭形动脉瘤,2例患者主动脉弓存在梭形动脉瘤,2例患者胸腹主动脉存在梭形动脉瘤,6例患者腹主动脉存在梭形动脉瘤。40例(55.6%)发生主动脉夹层,其中29例为A型主动脉夹层。主动脉根部修复包括8例单独瓣膜移植、25例Bentall复合瓣膜移植、26例采用纽扣技术的复合瓣膜移植、10例采用插入移植技术的复合瓣膜移植以及5例保留瓣膜手术。总体早期(30天)死亡率为7.9%。单独瓣膜移植手术的早期生存率为75%,复合瓣膜移植手术的早期生存率为99.2%。采用Bentall技术且冠状动脉开口重新附着分两层进行的患者未发生晚期冠状动脉裂开,但冠状动脉吻合为单层的患者中有50%发生晚期冠状动脉裂开。5例保留瓣膜手术患者中有2例出现主动脉瓣反流复发。采用纽扣技术的复合瓣膜移植患者10年无事件发生率为81.1%。有14例晚期死亡;残余主动脉夹层或破裂、复合移植物心内膜炎和心力衰竭是晚期死亡的主要原因。总之,患有心血管疾病的马方综合征患者可接受手术治疗,手术风险低且发病率低。尽管晚期心内膜炎仍然是一个严重问题,但我们认为马方综合征是保留瓣膜手术的禁忌证。由于主动脉其他区域存在晚期夹层或动脉瘤的可能性,马方综合征患者应无限期进行系列计算机断层扫描。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验